Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
ASP-3082 by Astellas Pharma for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
ASP-3082 is under clinical development by Astellas Pharma and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
ASP-3082 by Astellas Pharma for Metastatic Colorectal Cancer: Likelihood of Approval
ASP-3082 is under clinical development by Astellas Pharma and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...
ASP-3082 by Astellas Pharma for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
ASP-3082 is under clinical development by Astellas Pharma and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...